Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer.
Publication
, Journal Article
Ciarallo, A; Marcus, C; Taghipour, M; Subramaniam, RM
Published in: PET Clin
April 2015
"Fluorodeoxyglucose (FDG) PET/computed tomography (CT) is used most frequently in the surveillance of iodine-refractory differentiated thyroid cancer with increased thyroglobulin level after therapy. This article evaluates the impact of FDG-PET/CT on clinical management and the prognostic implications of a positive scan. In the studies reviewed, FDG-PET/CT changed the course of management in 14% to 78% of patients with suspected recurrence, and a positive scan was associated with poorer survival. Similar conclusions are supported in the literature for anaplastic and medullary thyroid cancers, although these are based on fewer studies on account of the lower prevalence of these subtypes."
Duke Scholars
Published In
PET Clin
DOI
EISSN
1879-9809
Publication Date
April 2015
Volume
10
Issue
2
Start / End Page
265 / 278
Location
United States
Related Subject Headings
- Young Adult
- Tomography, X-Ray Computed
- Thyroid Neoplasms
- Thyroid Carcinoma, Anaplastic
- Radiopharmaceuticals
- Prognosis
- Positron-Emission Tomography
- Nuclear Medicine & Medical Imaging
- Neoplasm Metastasis
- Multimodal Imaging
Citation
APA
Chicago
ICMJE
MLA
NLM
Ciarallo, A., Marcus, C., Taghipour, M., & Subramaniam, R. M. (2015). Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer. PET Clin, 10(2), 265–278. https://doi.org/10.1016/j.cpet.2014.12.009
Ciarallo, Anthony, Charles Marcus, Mehdi Taghipour, and Rathan M. Subramaniam. “Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer.” PET Clin 10, no. 2 (April 2015): 265–78. https://doi.org/10.1016/j.cpet.2014.12.009.
Ciarallo A, Marcus C, Taghipour M, Subramaniam RM. Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer. PET Clin. 2015 Apr;10(2):265–78.
Ciarallo, Anthony, et al. “Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer.” PET Clin, vol. 10, no. 2, Apr. 2015, pp. 265–78. Pubmed, doi:10.1016/j.cpet.2014.12.009.
Ciarallo A, Marcus C, Taghipour M, Subramaniam RM. Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer. PET Clin. 2015 Apr;10(2):265–278.
Published In
PET Clin
DOI
EISSN
1879-9809
Publication Date
April 2015
Volume
10
Issue
2
Start / End Page
265 / 278
Location
United States
Related Subject Headings
- Young Adult
- Tomography, X-Ray Computed
- Thyroid Neoplasms
- Thyroid Carcinoma, Anaplastic
- Radiopharmaceuticals
- Prognosis
- Positron-Emission Tomography
- Nuclear Medicine & Medical Imaging
- Neoplasm Metastasis
- Multimodal Imaging